Home » Topics » Regulatory

Regulatory
RSS

FDA approves new formulation of Gensi Laboratories' etoposide

Aug. 9, 1996

RPR's enoxaparin reduces risk of DVT following hip replacement

Aug. 9, 1996

Biovail's diltiazem covered under U.S. patent

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Lidocaine nasal drops shown effective for fast migraine pain relief

Aug. 9, 1996

Actiq to undergo phase III clinical trials

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996